Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3844) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP): 14-17 December 2009 11 Φεβρουάριος 2010Press releaseHuman European Medicines Agency updates on ongoing safety review of sibutramine: Weight-loss medicine assessed over cardiovascular concerns 11 Φεβρουάριος 2010Press releaseMedicines European Medicines Agency 2009 mid-year report shows it is still on target, despite influenza pandemic activities 11 Φεβρουάριος 2010Press releaseCorporateMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 18-21 January 2010 28 Ιανουάριος 2010Press releaseHuman Committee on Advanced Therapies (CAT) celebrates its first birthday 27 Ιανουάριος 2010Press releaseAdvanced therapies European Medicines Agency launches consultation on its Road Map to 2015 26 Ιανουάριος 2010Press releaseMedicines European Medicines Agency recommends suspension of marketing authorisation for sibutramine 22 Ιανουάριος 2010Press releaseMedicines European Medicines Agency gives first opinion on compassionate use 22 Ιανουάριος 2010Press releaseHumanMedicines European Medicines Agency updates on pandemic influenza 22 Ιανουάριος 2010Press releaseHumanMedicines European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri 21 Ιανουάριος 2010Press releaseMedicines 1 … 295 296 297 298 299 Page 299 of 385 300 301 302 303 … 385
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP): 14-17 December 2009 11 Φεβρουάριος 2010Press releaseHuman
European Medicines Agency updates on ongoing safety review of sibutramine: Weight-loss medicine assessed over cardiovascular concerns 11 Φεβρουάριος 2010Press releaseMedicines
European Medicines Agency 2009 mid-year report shows it is still on target, despite influenza pandemic activities 11 Φεβρουάριος 2010Press releaseCorporateMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 18-21 January 2010 28 Ιανουάριος 2010Press releaseHuman
Committee on Advanced Therapies (CAT) celebrates its first birthday 27 Ιανουάριος 2010Press releaseAdvanced therapies
European Medicines Agency launches consultation on its Road Map to 2015 26 Ιανουάριος 2010Press releaseMedicines
European Medicines Agency recommends suspension of marketing authorisation for sibutramine 22 Ιανουάριος 2010Press releaseMedicines
European Medicines Agency gives first opinion on compassionate use 22 Ιανουάριος 2010Press releaseHumanMedicines
European Medicines Agency updates on pandemic influenza 22 Ιανουάριος 2010Press releaseHumanMedicines
European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri 21 Ιανουάριος 2010Press releaseMedicines